APA (7th ed.) Citation

Liu, L., Cheng, Z., Wang, L., Zhang, L., Li, S., Li, S., . . . Guo, L. (2025). Efficacy and Safety of Dulaglutide Biosimilar LY05008 Versus the Reference Product Dulaglutide (Trulicity) in Chinese Adults With Type 2 Diabetes Mellitus: A Randomized, Open‐Label, Active Comparator Study. Wiley. https://doi.org/10.1111/1753-0407.70077

Chicago Style (17th ed.) Citation

Liu, Li, et al. Efficacy and Safety of Dulaglutide Biosimilar LY05008 Versus the Reference Product Dulaglutide (Trulicity) in Chinese Adults With Type 2 Diabetes Mellitus: A Randomized, Open‐Label, Active Comparator Study. Wiley, 2025. https://doi.org/10.1111/1753-0407.70077.

MLA (9th ed.) Citation

Liu, Li, et al. Efficacy and Safety of Dulaglutide Biosimilar LY05008 Versus the Reference Product Dulaglutide (Trulicity) in Chinese Adults With Type 2 Diabetes Mellitus: A Randomized, Open‐Label, Active Comparator Study. Wiley, 2025. https://doi.org/10.1111/1753-0407.70077.